Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype.

Zaunders J, Dyer WB, Churchill M, Munier CML, Cunningham PH, Suzuki K, McBride K, Hey-Nguyen W, Koelsch K, Wang B, Hiener B, Palmer S, Gorry PR, Bailey M, Xu Y, Danta M, Seddiki N, Cooper DA, Saksena NK, Sullivan JS, Riminton S, Learmont J, Kelleher AD.

J Virus Erad. 2019 Apr 1;5(2):73-83.

2.

A case of benign periosteal chondroma seeding into humeral medullary bone via percutaneous needle biopsy tract.

Learmont JP, Powell G, Slavin J, Facey M, Pianta M.

BJR Case Rep. 2015 May 7;1(1):20150104. doi: 10.1259/bjrcr.20150104. eCollection 2015.

3.

High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia.

Zulli A, Lau E, Wijaya BP, Jin X, Sutarga K, Schwartz GD, Learmont J, Wookey PJ, Zinellu A, Carru C, Hare DL.

Hypertension. 2009 Jun;53(6):1017-22. doi: 10.1161/HYPERTENSIONAHA.109.129924. Epub 2009 Apr 27.

PMID:
19398656
4.

Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.

Dyer WB, Zaunders JJ, Yuan FF, Wang B, Learmont JC, Geczy AF, Saksena NK, McPhee DA, Gorry PR, Sullivan JS.

Retrovirology. 2008 Dec 11;5:112. doi: 10.1186/1742-4690-5-112.

5.

Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages.

Wu JQ, Wang B, Belov L, Chrisp J, Learmont J, Dyer WB, Zaunders J, Cunningham AL, Dwyer DE, Saksena NK.

Retrovirology. 2007 Nov 26;4:83.

6.

Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo.

Gorry PR, Churchill M, Learmont J, Cherry C, Dyer WB, Wesselingh SL, Sullivan JS.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):390-4.

PMID:
17993857
7.

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

Gorry PR, McPhee DA, Verity E, Dyer WB, Wesselingh SL, Learmont J, Sullivan JS, Roche M, Zaunders JJ, Gabuzda D, Crowe SM, Mills J, Lewin SR, Brew BJ, Cunningham AL, Churchill MJ.

Retrovirology. 2007 Sep 23;4:66.

8.

Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source.

Gray L, Churchill MJ, Sterjovski J, Witlox K, Learmont JC, Sullivan JS, Wesselingh SL, Gabuzda D, Cunningham AL, McPhee DA, Gorry PR.

Virol J. 2007 Jul 16;4:75.

9.

Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions.

Verity EE, Zotos D, Wilson K, Chatfield C, Lawson VA, Dwyer DE, Cunningham A, Learmont J, Dyer W, Sullivan J, Churchill M, Wesselingh SL, Gabuzda D, Gorry PR, McPhee DA.

J Virol. 2007 Sep;81(17):9268-78. Epub 2007 Jun 13.

10.

Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source.

Churchill MJ, Rhodes DI, Learmont JC, Sullivan JS, Wesselingh SL, Cooke IR, Deacon NJ, Gorry PR.

J Virol. 2006 Jan;80(2):1047-52.

11.

In vivo replication kinetics of a nef-deleted strain of HIV-1.

Crowe SM, Ho DD, Marriott D, Brew B, Gorry PR, Sullivan JS, Learmont J, Mills J.

AIDS. 2005 May 20;19(8):842-3. No abstract available.

PMID:
15867504
12.

Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia.

Churchill M, Sterjovski J, Gray L, Cowley D, Chatfield C, Learmont J, Sullivan JS, Crowe SM, Mills J, Brew BJ, Wesselingh SL, McPhee DA, Gorry PR.

J Infect Dis. 2004 Dec 15;190(12):2181-6. Epub 2004 Nov 16.

PMID:
15551218
13.

High frequency of nonprogression 20 years after transfusion-transmitted human immunodeficiency virus type-1 infection.

Dyer WB, Learmont JC, Geczy AF, Sullivan JS.

Transfusion. 2004 Sep;44(9):1397-8. No abstract available.

PMID:
15318871
14.

The value of lookback to understanding blood-borne infectious diseases: the New South Wales' HIV experience.

Learmont JC, Phillips RS, Bickerton IJ.

Transfus Med Rev. 2002 Oct;16(4):315-24. Review.

PMID:
12415517
15.

An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).

Birch MR, Learmont JC, Dyer WB, Deacon NJ, Zaunders JJ, Saksena N, Cunningham AL, Mills J, Sullivan JS.

J Clin Virol. 2001 Oct;22(3):263-70.

PMID:
11564591
16.

Late diagnosis of three cases of transfusion-acquired HIV-1 infection.

Learmont JC, Raynes-Greenow CH, Branley JM, Frankum BS, Maddocks S, Iredell JR.

Med J Aust. 2000 Apr 3;172(7):349. No abstract available.

PMID:
10844926
17.

HLA and other host factors in transfusion-acquired HIV-1 infection.

Geczy AF, Kuipers H, Coolen M, Ashton LJ, Kennedy C, Ng G, Dodd R, Wallace R, Le T, Raynes-Greenow CH, Dyer WB, Learmont JC, Sullivan JS.

Hum Immunol. 2000 Feb;61(2):172-6.

PMID:
10717811
18.

Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.

Zaunders JJ, Geczy AF, Dyer WB, McIntyre LB, Cooley MA, Ashton LJ, Raynes-Greenow CH, Learmont J, Cooper DA, Sullivan JS.

AIDS Res Hum Retroviruses. 1999 Nov 20;15(17):1519-27.

PMID:
10580402
19.

Identification of a new recipient in the Sydney Blood Bank Cohort: a long-term HIV type 1-infected seroindeterminate individual.

Rhodes D, Solomon A, Bolton W, Wood J, Sullivan J, Learmont J, Deacon N.

AIDS Res Hum Retroviruses. 1999 Nov 1;15(16):1433-9.

PMID:
10555106
20.

The Sydney Blood Bank Cohort: a case-control study using a transfused HIV-1 seronegative group.

McIntyre LB, Geczy AF, Dyer WB, Learmont JC, Sullivan JS.

Ann Epidemiol. 1999 Oct;9(7):436-40.

PMID:
10501411
21.

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.

Learmont JC, Geczy AF, Mills J, Ashton LJ, Raynes-Greenow CH, Garsia RJ, Dyer WB, McIntyre L, Oelrichs RB, Rhodes DI, Deacon NJ, Sullivan JS.

N Engl J Med. 1999 Jun 3;340(22):1715-22.

22.

Cytokine profiles in a cohort of long-term survivors of transfusion-acquired HIV-1 infection.

Blasdall SA, Geczy AF, Raynes-Greenow CH, Dyer WB, McIntyre LB, Learmont JC, Sullivan JS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):97. No abstract available.

PMID:
9928738
23.
24.

Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function.

Cockell AP, Learmont JG, Smárason AK, Redman CW, Sargent IL, Poston L.

Br J Obstet Gynaecol. 1997 Feb;104(2):235-40.

PMID:
9070146
25.

Myogenic and flow-mediated responses in isolated mesenteric small arteries from pregnant and nonpregnant rats.

Learmont JG, Cockell AP, Knock GA, Poston L.

Am J Obstet Gynecol. 1996 May;174(5):1631-6.

PMID:
9065143
26.

Response: Attenuated HIV Vaccine: Caveats.

Deacon NJ, McPhee DA, Crowe S, Learmont J, Mills J.

Science. 1996 Mar 29;271(5257):1791-2. No abstract available.

PMID:
17812357
27.

Nitric oxide is involved in flow-induced dilation of isolated human small fetoplacental arteries.

Learmont JG, Poston L.

Am J Obstet Gynecol. 1996 Feb;174(2):583-8.

PMID:
8623789
28.

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J.

Science. 1995 Nov 10;270(5238):988-91.

PMID:
7481804
29.

HIV and AIDS.

Sullivan JS, Learmont JC, Geczy AF, Dyer W.

Nature. 1995 Nov 2;378(6552):10. No abstract available.

PMID:
7477274
30.

A direct association between HIV and AIDS in blood transfusion donors and recipients.

Sullivan JS, Learmont J, Lumley T, Geczy AF, Cook L, Dyer WB.

AIDS Res Hum Retroviruses. 1995 Oct;11(10):1147-8. No abstract available.

PMID:
8573368
31.

Nitric oxide synthase activities in placental tissue from normotensive, pre-eclamptic and growth retarded pregnancies.

Morris NH, Sooranna SR, Learmont JG, Poston L, Ramsey B, Pearson JD, Steer PJ.

Br J Obstet Gynaecol. 1995 Sep;102(9):711-4.

PMID:
7547761
32.

Heterosexually acquired HIV infection in female blood donors: case series between 1985-1990.

McLaws ML, Learmont J, Wylie B.

AIDS Care. 1995;7(5):631-8.

PMID:
8652697
33.

Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor.

Learmont J, Cook L, Dunckley H, Sullivan JS.

AIDS Res Hum Retroviruses. 1995 Jan;11(1):1. No abstract available.

PMID:
7734182
34.

Non-parametric analysis of transfusion-related HIV and AIDS incidence data.

Motika M, Becker NG, Wylie B, Learmont J, Kaldor J.

Stat Med. 1994 Oct 15-30;13(19-20):2043-58.

PMID:
7846409
35.

HIV infection in recipients of blood products from donors with known duration of infection.

Ashton LJ, Learmont J, Luo K, Wylie B, Stewart G, Kaldor JM.

Lancet. 1994 Sep 10;344(8924):718-20.

PMID:
7915778
36.

Development of AIDS in people with transfusion-acquired HIV infection.

Kopec-Schrader E, Tindall B, Learmont J, Wylie B, Kaldor JM.

AIDS. 1993 Jul;7(7):1009-13.

PMID:
8357547
37.

Long-term symptomless HIV-1 infection in recipients of blood products from a single donor.

Learmont J, Tindall B, Evans L, Cunningham A, Cunningham P, Wells J, Penny R, Kaldor J, Cooper DA.

Lancet. 1992 Oct 10;340(8824):863-7.

PMID:
1357294
38.

Evaluation of a fetal risk-scoring system.

Chard T, Learmont J, Carroll S, Hudson C, Lloyd DS, Sloan D.

Am J Perinatol. 1992 Sep-Nov;9(5-6):388-93. Review.

PMID:
1418141
39.

Susceptibility of postmenopausal women to infection with HIV during vaginal intercourse.

Dwyer JM, Penny R, Gatenby PA, Learmont J.

Med J Aust. 1990 Sep 3;153(5):299. No abstract available.

PMID:
2392075
40.

Survival of patients with the acquired immunodeficiency syndrome.

Learmont J.

Med J Aust. 1989 Nov 6;151(9):538-9. No abstract available.

PMID:
2811728

Supplemental Content

Loading ...
Support Center